Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Retrovirus Life Cycles

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...

Retroviruses

Retroviruses

Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.

Sexually Transmitted Infections

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...

Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...

Size and Structure of Viral Genomes

Size and Structure of Viral Genomes

Viral genomes exhibit remarkable diversity in size, structure, and composition, influencing their replication strategies and interactions with host cells. These genomes consist of either DNA or RNA and may be linear or circular. Additionally, they can be single-stranded or double-stranded, with each configuration affecting how the virus propagates within a host. RNA viruses, for instance, generally have smaller genomes than DNA viruses, a factor that contributes to their high mutation rates and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Genome-wide association study of untargeted plasma metabolomic profiles identifies host genetic regulation in people with HIV.

HGG advances·2026

Same author

Genetic and transcriptomic signatures of host control in HIV-1 infection.

Retrovirology·2026

Same author

Addressing the interdependencies: the role of global health diplomacy in designing One Health governance.

Science in One Health·2026

Same author

Diagnosing established and acute HIV in the context of facility-based HIV testing services in rural Eswatini: a cross-sectional study.

Sexually transmitted infections·2026

Same author

Acceptance and preferences for different nicotine substitute products to reduce tobacco smoking in people living with HIV: Results from an internal pilot study of a randomized trial.

Tobacco induced diseases·2026

Same author

Improving cohort coverage estimation using a data triangulation framework: the Swiss HIV Cohort Study example.

AIDS (London, England)·2026

Search research articles

Related Experiment Video

Updated: Apr 26, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

[Antiretroviral therapy].

Amrei von Braun¹, Hansjakob Furrer², Manuel Battegay³

¹Klinik für Infektionskrankheiten und Spitalhygiene, Universitätsspital Zürich (USZ), Universität Zürich.

Therapeutische Umschau. Revue Therapeutique

|August 6, 2014

Summary

This summary is machine-generated.

Antiretroviral therapy has transformed HIV from a fatal illness into a manageable chronic condition. Successful treatment also prevents HIV transmission, aiding global pandemic control efforts.

More Related Videos

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

Related Experiment Videos

Last Updated: Apr 26, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

Area of Science:

Medical Science
Virology
Pharmacology

Context:

Antiretroviral therapy (ART) represents a significant medical advancement for Human Immunodeficiency Virus (HIV) management.
Historically, an HIV diagnosis was a near-certain death sentence, but effective drugs have rendered it a manageable chronic condition.

Purpose:

To highlight the success of modern antiretroviral therapy in managing HIV.
To underscore the importance of physician knowledge regarding HIV complexity, including resistance, immune reconstitution, and drug interactions.
To emphasize the critical role of patient adherence in successful HIV treatment.

Summary:

Highly effective and well-tolerated antiretroviral drugs have revolutionized HIV treatment, enabling patients to achieve near-normal life expectancy.
Successfully treated individuals on ART are no longer infectious, a crucial factor in global HIV pandemic control strategies.
Despite successes, managing HIV requires deep physician understanding of viral resistance, immune reconstitution, drug toxicity, and drug-drug interactions, with long-term side effects still under investigation.

Impact:

ART has dramatically improved quality of life and life expectancy for people living with HIV.
ART contributes significantly to reducing HIV transmission rates globally.
Continued research into long-term effects and adherence strategies is vital for optimizing HIV care.